首页> 中文期刊> 《中国性科学》 >苁蓉益肾颗粒联合前列康治疗慢性前列腺炎的临床研究

苁蓉益肾颗粒联合前列康治疗慢性前列腺炎的临床研究

         

摘要

Objectives:To explore the clinical curative effect of Congrong Yy-shen granule joint Qianlie Kang tablets for chronic prostatitis.Methods:90 patients with chronic prostatitis (CP) in our hospital from June 2015 to June 2016 were included and randomly divided into the treatment group to receive Congrong Yy-shen granule joint Qianlie Kang tablets and the Congrong Yy-shen granule control group and the Qianlie Kang tablet control group,each of 30 cases and all for 12 weeks.The NIH-CPSI scores,the scores of traditional Chinese medicine syndrome,EPS examination and hemorheology examination were observed before and after treatment respectively,and the treatment efficacy was compared.Results:After treatment,all the EPS examination,the scores of traditional Chinese medicine syndrome and hemorheology in all the groups were improved and the NIH-CPSI scores significantly decreased,more significant in the treatment group than the other two control groups with significant difference.Compared with the two control groups,the pain relief and daily life ability were improved in the treatment group.Conclusion:Joint use of Congrong Yy-shen granule and Qianlie Kang tablets has good clinical curative effect,which can effectively relieve the symptom of urination and improve the patients' quality of life.%目的:观察苁蓉益肾颗粒对慢性前列腺炎(chronic prostatitis,CP)的临床治疗效果.方法:纳入2015年6月至2016年6月在我院就诊的CP患者90例.采用随机单盲对照的设计方法,将其分为苁蓉益肾颗粒结合前列康治疗组、苁蓉益肾颗粒对照组和前列康对照组,每组各30例,连续用药12周.治疗前后分别观察NIH-CPSI评分、中医证候评分、EPS检查及血液流变学检测,将数据进行统计学分析,苁蓉益肾颗粒联合前列康治疗CP的临床有效性.结果:治疗组、苁蓉益肾颗粒对照组和前列康对照组在治疗后EPS检查、中医证候评分、血流变学均较治疗前有所改善,NIH-CPSI总分明显下降,且治疗组明显低于两对照组,有统计学差异(P<0.05);苁蓉益肾颗粒结合前列康治疗组与苁蓉益肾颗粒对照组和前列康对照组相比较,在改善日常质量、减轻疼痛等方面更优.结论:CP患者采用苁蓉益肾颗粒配合前列康治疗有较好的临床疗效,能有效缓解患者症状,改善患者生活质量.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号